I need the panel's advice, please. What is current thinking on review
periods for depressed patients on medication (in the main of course, SSRIs)?
Clearly the answer to this might include the phrase "it depends on the
individual circumstances of the patient" but I am thinking of the stable
patient who perhaps has shown a good response to the medication and is
perhaps 2-4 months into the treatment - or perhaps someone who has been
taking an SSRI for many months or even years and is keen to continue.
2-monthly scripts and reviews? 3-monthly? 6-monthly? Does anyone have a
"norm" for this, or even a practice policy? No need for long detailed
answers - I just want to get a feel for what others do.
Paul Skinner
|